Over the past four years, a controversy has erupted over whether to routinely give girls the new vaccine against the human papillomavirus (HPV), a sexually transmitted virus that can cause genital warts and cervical cancer. Now we can have the debate all over again--but this time, with boys. An advisory panel of the Food and Drug Administration has recommended that the vaccine be made available for boys as well. While boys are obviously not at risk for cervical cancer, HPV can give them genital warts and, in very rare cases, can lead to anal or penile cancer. The pharmaceutical giant Merck makes the first HPV vaccine available in the United States, Gardasil, which is considered most effective when given to young people who aren't yet sexually active and therefore haven't yet encountered the virus. But analyst Tim Anderson says that the regime of three shots over six months may deter ...
The Controversial HPV Vaccine May Be Approved for Boys, Too
The human papillomavirus vaccine is now recommended for boys, raising discussions about its significance against genital warts and cancer risks.
More on Discover
Stay Curious
SubscribeTo The Magazine
Save up to 40% off the cover price when you subscribe to Discover magazine.
Subscribe